COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment.

Research Base: ECOG-ACRIN Cancer Research Group
NCT ID: NCT03233191
NCI Protocol Number: ECOG-ACRIN-EA1151
Status: Recruiting

For more information see



Breast Screening

Trial Type

Screening/Early Detection

See a list of participating sites on